𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A new MAGE-4 antigenic peptide recognized by cytolytic T lymphocytes on HLA–A24 carcinoma cells

✍ Scribed by Sabrina Ottaviani; Didier Colau; Pierre van der Bruggen; Pierre van der Bruggen

Publisher
Springer-Verlag
Year
2005
Tongue
English
Weight
269 KB
Volume
55
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A MAGE-A4 peptide presented by HLA-A2 is
A MAGE-A4 peptide presented by HLA-A2 is recognized by cytolytic T lymphocytes
✍ Marie-Thérèse Duffour; Pascal Chaux; Christophe Lurquin; Guy Cornelis; Thierry B 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB

The MAGE-encoded antigens that are recognized by cytolytic T lymphocytes (CTL) are shared by many tumors and are strictly tumor specific. Clinical trials involving therapeutic vaccination of cancer patients with MAGE antigenic peptides or proteins are in progress. To increase the range of patients e

Lysis of human chondrosarcoma cells by c
Lysis of human chondrosarcoma cells by cytolytic T lymphocytes recognizing a MAGE-A3 antigen presented by HLA-A1 molecules
✍ Eric M. Bluman; Pierre G. Coulie; Sun Xiaojuan; Jason Machan; Chouzao Lin; Patri 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 203 KB

## Abstract Treatment of chondrosarcomas is limited to resection because these tumors are unresponsive to standard adjuvant treatments, such as chemotherapy and radiation. We have previously shown that high‐grade chondrosarcomas express unspecified members of the Melanoma Antigen (MAGE) gene family